The Clinical Value of the Nitric Oxide System Components in Asthma and COPD - Trial NCT04456491
Access comprehensive clinical trial information for NCT04456491 through Pure Global AI's free database. This phase not specified trial is sponsored by Ryazan State Medical University and is currently Recruiting. The study focuses on Asthma,COPD. Target enrollment is 240 participants.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.
Study Focus
Observational
Sponsor & Location
Ryazan State Medical University
Timeline & Enrollment
N/A
Sep 01, 2021
Jun 30, 2025
Primary Outcome
Combined outcome - clinical worsening
Summary
It is planned to conduct a study of nitric oxide metabolites (nitrates and nitrites),
 L-arginine, arginase-1, and asymmetric dimethylarginine in patients with bronchial asthma and
 chronic obstructive pulmonary disease, followed by observation to assess the prognosis of the
 disease.
ICD-10 Classifications
Data Source
ClinicalTrials.gov
NCT04456491
Non-Device Trial